Approach and Practical Management of Treatable Adult-onset Progressive Ataxias

Course Purpose

This MDS Interactive module provides learners with an overview of treatable adult-onset progressive ataxias.

Learning Objectives

After participating in this activity, the learner will be able to:

1. Describe a cost-effective, evidence-based diagnostic approach for a patient with adult-onset progressive sporadic ataxia (including a classification system for adult-onset progressive cerebellar ataxias). 

2. Identify clinical manifestations and ancillary investigations for treatable sporadic adult-onset ataxias. 

3. Discuss pharmacological therapeutic options for treatable adult-onsetprogressive ataxias

Intended Audience

This activity is intended for students, residents, primary care providers, internists, allied health, non-neurology specialists, and industry who have limited to no movement disorder experience.

Accreditation Credit

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement

The International Parkinson and Movement Disorder Society designates this education activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Method of Participation

Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed in the Accreditation Statement, it is your responsibility to contact your licensing/certification board to determine course eligibility for your board requirement.

Faculty Disclosure

All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available below. All relevant financial relationships have been mitigated in advance of this program.

Marina Picillo: Author
Nothing to Disclose

Danish Bhatti: Author
Consultant: Acadia, Allergan pakistan (barret hodgson), Medtronic, Amneal, Accorda
Speaker: AbbVie, Adamas, Accadia, Allergan Pakistan (barret hodgson), PharmEvo Pakistan, Amneal, Acorda

Chandler Gill: Reviewer
Nothing to Disclose

Staff Disclosure

MDS staff members involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.

Hardware and Software Requirements

1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.

2. Compatible with Windows PC and MAC (256 MB of RAM or higher)

3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher

4. Adobe Flash Player 12.0 (or higher).

5. Adobe Reader to print certificate.

Contact Us

MDS Secretariat Liaison

Ericka Blackford